PARIS — French health authorities have approved the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus. The independent public health body HAS Friday night announced “a greenlight for the preventive use of Evusheld… for patients with a very high-risk of contracting a severe form of Covid-19”. Evusheld, which is made from a combination of two monoclonal antibodies, is administered in two injections. Monoclonal antibodies — which recognise a specific molecule of the target virus or bacteria — are synthetic versions of natural antibodies. For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

Source: Philippine Daily Inquirer December 12, 2021 15:33 UTC